WASHINGTON — Several lots of a prescription ADHD medication have been recalled due to some failed lab tests, according to FDA Enforcement Reports .

The nationwide recall covers several batches of the commonly used medication Lisdexamfetamine Dimesylate, a generic version of the ADHD medication Vyvanse.

Sun Pharmaceutical Industries Inc. recalled the specified lots due to "Failed Dissolution Specifications," meaning the sample pills failed to dissolve properly during testing.

If this sounds familiar, that's because it's the same issue that led to a recall of more than 140,000 bottles of a popular cholesterol medication last month.

The recall was issued on Oct. 28, and the FDA classified it as a Class II recall on Oct. 30, meaning use "may cause temporary health consequences, but

See Full Page